Investor events Upcoming Events No upcoming events at this time. Archived Events Mar 12, 2026 5:00 PM EDT Nektar Therapeutics Q4 2025 Financial Results Click here for webcast Mar 4, 2026 9:10 AM EST TD Cowen 46th Annual Health Care Conference Click here for webcast Supporting Materials TD Cowen 46th Annual Health Care Conference Presentation 3.1 MB Feb 10, 2026 8:00 AM EST Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis Click here for webcast Supporting Materials Phase 2b REZOLVE-AD: Topline Results from 36-Week Maintenance Period 2.9 MB Dec 16, 2025 8:00 AM EST Nektar Therapeutics Analyst and Investor Event To Discuss REZOLVE-AA Topline Results Click here for webcast Supporting Materials Phase 2b REZOLVE-AA Topline Results from 36-Week Induction Treatment Period 4.6 MB Nov 20, 2025 11:00 AM GMT Jefferies Global Healthcare Conference in London Click here for webcast Nov 6, 2025 5:00 PM EST Nektar Therapeutics Q3 2025 Financial Results Click here for webcast Contact IR Print Page RSS Email Alerts
Upcoming Events No upcoming events at this time. Archived Events Mar 12, 2026 5:00 PM EDT Nektar Therapeutics Q4 2025 Financial Results Click here for webcast Mar 4, 2026 9:10 AM EST TD Cowen 46th Annual Health Care Conference Click here for webcast Supporting Materials TD Cowen 46th Annual Health Care Conference Presentation 3.1 MB Feb 10, 2026 8:00 AM EST Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis Click here for webcast Supporting Materials Phase 2b REZOLVE-AD: Topline Results from 36-Week Maintenance Period 2.9 MB Dec 16, 2025 8:00 AM EST Nektar Therapeutics Analyst and Investor Event To Discuss REZOLVE-AA Topline Results Click here for webcast Supporting Materials Phase 2b REZOLVE-AA Topline Results from 36-Week Induction Treatment Period 4.6 MB Nov 20, 2025 11:00 AM GMT Jefferies Global Healthcare Conference in London Click here for webcast Nov 6, 2025 5:00 PM EST Nektar Therapeutics Q3 2025 Financial Results Click here for webcast
Mar 4, 2026 9:10 AM EST TD Cowen 46th Annual Health Care Conference Click here for webcast Supporting Materials TD Cowen 46th Annual Health Care Conference Presentation 3.1 MB
Feb 10, 2026 8:00 AM EST Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis Click here for webcast Supporting Materials Phase 2b REZOLVE-AD: Topline Results from 36-Week Maintenance Period 2.9 MB
Dec 16, 2025 8:00 AM EST Nektar Therapeutics Analyst and Investor Event To Discuss REZOLVE-AA Topline Results Click here for webcast Supporting Materials Phase 2b REZOLVE-AA Topline Results from 36-Week Induction Treatment Period 4.6 MB
